The Cytokine Society is proud to congratulate several of our members who were recently recognized by the American Society for Microbiology (ASM) and the American Association of Immunologists (AAI) for their outstanding contributions to science. These honors reflect the exceptional caliber of research within our community. Elected to the American [READ MORE]
I head the Immunoregulation research group at the Max-Planck-Institute of Biochemistry in Martinsried (Germany), and my group works on the complex intersection between immune regulation and metabolism. Out of the lab, I like cooking, and I spend a lot of time perfecting dishes. I also travel a lot, I love [READ MORE]
Dr. Zhian (Anthony) Chen has compiled the following review articles of relevance to researchers in the field of cytokine, chemokine and interferon biology. Dr. Chen is a Senior Research Fellow and Group Leader at the University of Queensland Frazer Institute. They lead a team under the UQ Health Research Accelerator [READ MORE]
2026 has started with good news for young interferon researchers of the Cytokine Society, as a new travel award will be established this year in the name of Robert Blackburn. It will consist of $1,000, and it is aimed at students and postdocs planning to attend Cytokines2026 meeting in Glasgow. [READ MORE]
I run a laboratory at Rutgers New Jersey Medical School in Newark NJ USA. I study host-pathogen interactions as I find both microbiology and immunology interesting. So, we have projects on bacterial pathogenesis as well as innate pathways important for host defense as well trying to understand specific cells important [READ MORE]
A Comprehensive Overview of Current Membership Demographics and Trends Report Date: January 31, 2026 Executive Summary As of January 31, 2026, The Cytokine Society maintains a robust international membership of 963 individuals, spanning multiple continents and representing diverse career stages from students to emeritus members. This report provides a detailed [READ MORE]
ClinicalTrials.gov ID NCT06915974 Sponsor Ain Shams University Information provided by Ain Shams University (Responsible Party) Last Update Posted 2025-04-08 Brief Summary The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early [READ MORE]
ClinicalTrials.gov ID NCT06642207 Sponsor Sohag University Information provided by Manar Gamal Abdelfattah, Sohag University (Responsible Party) Last Update Posted 2024-10-30 Brief Summary Ankylosing spondylitis (AS) is a chronic, inflammatory autoimmune disease characterized by axial bone inflammation. The main clinical manifestations include back pain and progressive spinal rigidity, as well as [READ MORE]
ClinicalTrials.gov ID NCT06062966 Sponsor Virginia Commonwealth University Information provided by Virginia Commonwealth University (Responsible Party) Last Update Posted 2025-04-27 Brief Summary End-stage heart failure (HF) is a progressive illness with a mortality rate similar to most advanced cancers.Roughly 5% of patients with HF have end-stage disease that is refractory to [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
